<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e>) is a <z:hpo ids='HP_0002664'>neoplasm</z:hpo> of T-lymphocytes, and human T-cell lymphotropic virus type-I (HTLV-I) is etiologically considered as the causative virus of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The karyotypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e> are very complex in both number and structure, although no specific karyotype abnormalities have been identified </plain></SENT>
<SENT sid="2" pm="."><plain>HTLV-I is thought to integrate its provirus into random sites in host chromosomal DNA and induces <z:mp ids='MP_0008866'>chromosomal instability</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The BUB gene is a component of the mitotic checkpoint in budding yeast </plain></SENT>
<SENT sid="4" pm="."><plain>Recently, human homologues of the BUB were identified and mutant alleles of hBUB1 and hBUBR1 were detected in two <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cell lines, which showed microsatellite instability (MIN) </plain></SENT>
<SENT sid="5" pm="."><plain>In vitro, BUB proteins form a complex of monomers </plain></SENT>
<SENT sid="6" pm="."><plain>These proteins interact with the human MAD1 gene product, a target of the HTLV-1 tax oncogene </plain></SENT>
<SENT sid="7" pm="."><plain>We examined the role of checkpoint gene in the chromosomal abnormalities of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e> by investigating mutations of hBUB1 and hBUBR1, and MIN of replication errors of BAX, insulin-like growth factor, and transforming growth factor beta type II </plain></SENT>
<SENT sid="8" pm="."><plain>We analyzed ten cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e> and eight B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (five diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, three follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>) </plain></SENT>
<SENT sid="9" pm="."><plain>Complex chromosomal abnormalities were detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e>, while B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> showed only simple or minimal chromosomal abnormalities </plain></SENT>
<SENT sid="10" pm="."><plain>Significant mutations/deletion of hBUB1 or hBUBR1 were detected in four of ten cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e>, including two heterozygous point mutations, one homozygous point mutation, and one with a 47 bp deletion </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, only one of eight B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> showed nonsense mutation of hBUBR1 </plain></SENT>
<SENT sid="12" pm="."><plain>None of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e> and B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> showed MIN </plain></SENT>
<SENT sid="13" pm="."><plain>In the multistage process of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e>, our findings indicate that mutations of mitotic checkpoint genes may play an important role in the induction of complex chromosomal abnormalities </plain></SENT>
</text></document>